MSD Chief AI Officer Highlights AI Integration in Drug Discovery and Development

MSD's Chief AI Officer, Anton Groom, emphasizes the integration of AI models like TEDDY and KERMT with scientific expertise to enhance drug discovery. These AI tools assist in identifying drug targets and refining lead compounds, accelerating medicine development, with two AI-discovered molecules currently in clinical trials. Groom highlights AI as a talent multiplier driving patient impact across drug discovery, clinical development, manufacturing, and commercialization, reflecting broader industry trends toward AI adoption in pharma.